Olivier Romano

Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator–activated receptor-γ

Christel Rousseaux, Bruno Lefebvre, Laurent Dubuquoy et al. · The Journal of Experimental Medicine · 2005 · 511 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)

Astrid Lièvre, Anthony Turpin, Isabelle Ray‐Coquard et al. · European Journal of Cancer · 2020 · 164 citations · Full text

Medicine, Infectious Diseases, Oncology +14

Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial

Jacobus Pfisterer, Catherine Shannon, Klaus Baumann et al. · The Lancet Oncology · 2020 · 162 citations

Medicine, Gynecology, Oncology +14

Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma

Amani Asnacios, Olivier Romano, Chloé Tesmoingt et al. · Cancer · 2008 · 138 citations

Medicine, Oncology, Pharmacology +17

Lack of usefulness of epidermal growth factor receptor expression determination for cetuximab therapy in patients with colorectal cancer

Mohamed Hebbar, Christophe Desauw, Olivier Romano et al. · Anti-Cancer Drugs · 2006 · 111 citations

Medicine, Oncology, Pharmacology +14